Is EIKANCE 0.01% Atropine Sulfate Eye Drops safe for long-term continuous use without side effects?

0.01% atropine sulfate eye drops (trade name EIKANCE) is a low-concentration atropine preparation mainly used to control the progression of myopia in children. Compared with traditional high-concentration atropine, atropine eye drops with a concentration of 0.01% are recommended by more and more ophthalmologists for long-term myopia control due to their lower drug concentration and relatively fewer side effects. However, whether it can be used continuously for a long time without any side effects still needs to be treated with caution.

First of all, 0.01%The low concentration of atropine sulfate eye drops is designed to minimize side effects while exerting a certain myopia suppression effect. Clinical studies have shown that atropine at this concentration can be used safely in most children. Common side effects, such as slight stinging of the eyes, dryness or photophobia, are usually mild and short-lived, and the occurrence rate is much lower than with high concentrations of atropine.

Secondly, although long-term continuous use of 0.01% atropine is relatively safe, regular eye examinations by a professional ophthalmologist are still required. Because each child's eye condition and drug response are different, a small number of patients may experience mild pupil dilation or weakened accommodation function, and a very small number may even experience changes in intraocular pressure. The doctor will adjust the usage plan according to the specific situation to ensure the safety of the medication.

Finally, 0.01%Atropine sulfate eye drops have lower side effects, but the statement "safe and without side effects" is not entirely accurate. There are potential risks with any medication, especially when used long-term. Therefore, parents and patients should strictly follow the doctor's instructions, not increase or decrease the dosage or stop the medication without authorization, follow up regularly to evaluate the effect and safety, and use medication scientifically to protect children's visual health to the greatest extent.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf